Senate Appropriations Committee Advances FY 2025 Funding Bill with Focus on Rare Disease and AI
On July 11, 2024, the Senate Appropriations Committee met for a full committee markup and…
Browsing: State
FTC Report Unveils PBM Impact on Drug Costs and Accessibility
On July 9, 2024, the Federal Trade Commission (FTC) released an interim report highlighting the…
Aimed Alliance Provides Comment on Medicare Drug Price Negotiation Program Guidance
On July 2, 2024, Aimed Alliance submitted a comment to the Centers for Medicare &…
Oregon PDAB Postpones Drug Reviews Until 2025
On June 26, 2024, the Oregon Prescription Drug Affordability Board (PDAB) voted to pause all…
Oklahoma Seeks Supreme Court Review of Tenth Circuit Ruling on State PBM Regulation
The Tenth Circuit Court of Appeals, in Pharmaceutical Care Management Association (PCMA) v. Mulready, struck…
Surgeon General Declares Firearm Violence a Public Health Crisis
On June 25, 2024, U.S. Surgeon General Dr. Vivek Murthy issued an Advisory on firearm…
IRA May Not Lower Medicare Part D Out-of-Pocket Costs
A new analysis found that the Inflation Reduction Act (IRA) could raise out-of-pocket costs for…
Colorado’s PDAB Declares Third Drug Unaffordable
On June 14, the Colorado Prescription Drug Affordability Board (PDAB) voted that a prescription drug…
AFP Taskforce Sends Letter to HHS Regarding Upcoming Rulemaking
On May 31, 2024, Aimed Alliance joined 19 other members of the Alternative Funding Program…
Congress Re-Introduces Bill to Streamline Medicare Advantage Prior Authorizations
On June 12, House and Senate leaders reintroduced the bipartisan Improving Seniors’ Timely Access to…